Generic Injectable Market to Expand with Significant CAGR During 2019-2029

1
Generic Injectable Market to Expand with
Significant CAGR During 2019-2029

• March 2020

Report Id REP-GB-6051 Published On
Feb-2020 Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Generic Injectable Market Analysis

• Generic Injectable Market to Expand with
  Significant CAGR During 2019-2029
• Currently at a nascent stage, the global generic
  injectable market is projected to witness
  exponential growth in sales at around 12 CAGR
  during 2019 - 2029. Over the course of forecast
  period, generic injectable sales will experience
  3X growth, as indicated by a new Future Market
  Insights (FMI) study. Increasing patient
  preference for self-administration of drugs is
  primarily developing a fertile ground for the
  generic injectable market, says the report.
• "The generic pharmaceuticals sector is gaining a
  boost from frequent FDA approvals. Launch of
  low-cost injectables through investments in
  consolidations and mergers has been a major
  highlight," states the FMI report.
• Key Takeaways Generic Injectable Market
• Demand for monoclonal antibodies (mAbs) would
  remain significant vaccines are gaining
  traction.
• Generic injectable market continues to see
  emergence of high-value opportunities in North
  America and Europe.
• Asian markets would capture investors' attention,
  owing to solid growth in pharma production
  capacities and technology penetration.
• High preference for small molecule drugs will
  prevail

5
Generic Injectable Market Analysis

• Generic injectables continue to witness
  significant adoption in pain management.
• Large molecule injectables are set to outperform
  their small counterparts by 2022.
• Key Market Growth Drivers
• Expansion of orphan drug and parenteral products
  spaces remains a strong factor driving generic
  injectable sales.
• Increasing preference for cost-efficient
  biologics such as mAbs and vaccines over drugs is
  in favor of market growth.
• Reduced development time and increasing
  manufacturers' investments in consolidation are
  bolstering demand for generic injectables.
• Key Restraints
• Hefty operational costs will remain the key
  constraint facing generic injectable
  manufacturers.
• Tightening competition from low-cost
  manufacturers continues to challenge large-scale
  players in generic injectable market.

6
Generic Injectable Market Analysis

• Competition Analysis Generic Injectable Market
• This FMI study has covered some of the most
  prominent companies active in the generic
  injectable market, which include, but are not
  limited to, Pfizer Inc., Hospira Inc., Hikma, and
  Mylan. Key market players continue to maintain
  their strategic focus on expansion of business
  through mergers. Entering strategic distribution
  agreements will be a preferred move of market
  leaders in an effort to capture the untapped
  growth potential of generic injectable market.
• Development of new development pipelines and
  extension of product portfolios continue to be
  the key strategies of players that look forward
  to unlock opportunities in the US generic
  injectable market. Increasing competition to
  penetrate developed regional markets is
  attracting investments towards introduction of
  patented complex biologics. Association with CMOs
  and CDMOs will be a profitable developmental
  strategy in terms of productivity and operational
  costs, says the report.
• More about the Report
• This Future Market Insights study of 239 pages
  offers actionable insights on the generic
  injectable market. The market analysis is based
  on product (monoclonal antibodies,
  immunoglobulin, cytokines, insulin, peptide
  hormones, blood factors, peptide antibiotics,
  vaccines, small molecule antibiotics,
  chemotherapy agents, and others), molecule type
  (small molecule and large molecule), application
  (oncology, infectious diseases, diabetes, blood
  disorders, hormonal disorders, musculoskeletal
  disorders, CNS diseases, pain management, and
  cardiovascular diseases), route of administration
  (IV, IM, and SC), and distribution channels
  (hospital pharmacies, retail pharmacies, drug
  stores, and online pharmacies) across seven
  regions (Latin America, North America, Europe,
  South Asia, East Asia, Oceania, and MEA).

7
Generic Injectable Market Analysis

• Sourcehttps//www.accesswire.com/578595/Generic-I
  njectable-Sales-Set-to-Grow-Three-fold-Between-201
  9-and-2029-Biologics-over-Drugs-Trend-Assists-Mark
  et-Growth-Concludes-Future-Market-Insights
• Explore FMI's Detailed Coverage of Related
  Markets
• Corneal Ulcer Treatment Market
• Juvenile Idiopathic Arthritis Diagnostics Market
• About Future Market Insights (FMI)
• Future Market Insights (FMI) is a leading
  provider of market intelligence and consulting
  services, serving clients in over 150 countries.
  FMI is headquartered in London, the global
  financial capital, and has delivery centers in
  the U.S. and India. FMI's latest market research
  reports and industry analysis help businesses
  navigate challenges and take critical decisions
  with confidence and clarity amidst breakneck
  competition.

8
Generic Injectable Market Analysis

• CONTACT 
• Abhishek BudholiyaUnit No AU-01-H Gold Tower
  (AU), Plot No JLT-PH1-I3A,Jumeirah Lakes
  Towers, Dubai,United Arab EmiratesMARKET ACCESS
  DMCC InitiativeFor Sales Enquiries
  sales_at_futuremarketinsights.comFor Media
  Enquiries press_at_futuremarketinsights.comFuture
  Market Insights

9
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)